SOAP
Clinical SOAP Assignment 2
Spring 2020 CPSC 3150
Background Information and HPI
Patient arrival- April 1, 2020 to a local level-1 trauma medical center
Chief complaint(s)- dry nonproductive cough, shortness of breath, general fatigue, loss of appetite, intermittent fever, rhinorrhea
Age and gender- 45-year-old male, Caucasian
Smoking history- never been a smoker
Pulmonary history- no diagnosed lung disease
Height and weight- 5 foot 10 inches, 175 lbs.
Work history- assistant manager at a local grocery store
Home therapy- no home oxygen, Metformin, lisinopril, and atorvastatin
Comorbidities- diabetes, hypertension, and hypertriglyceridemia
Subjective Information
Upon patient interview, the patient disclosed the following:
· Signs and symptoms of illness began four days prior to seeking medical care
· Began as relatively mild but seems to be getting worse
· Cough is strong and frequent but nonproductive
· Feels like he cannot “catch his breath”
· Has not felt like doing much and called in sick to work yesterday
· Some nausea leading to loss of appetite
· Treating low grade fever with Tylenol as needed
· Nasal secretions are clear and watery, patient associates with seasonal allergies
· Patient denies any chest pain
· Has not been wearing a mask to work
Providers perform a thorough physical examination and diagnostic testing.
Objective Information
Physical assessment- patient was alert to person, place, and time; no cyanosis or clubbing noted; no pitting edema present; normal body habitus; no signs of respiratory distress. Inspection, palpation, and percussion revealed no chest abnormalities.
Initial vital signs- BP 135/88, HR 110, RR 16, Temperature 99.5 F, Sp02 95% on RA
ECG- sinus tachycardia
CXR- Initial image on 4/1 demonstrated no acute changes
Bilateral breath sounds- rhonchi was heard bilaterally
ABG- pH 7.39, PaC02 42 mmHg, Pa02 80 mmHg, HC03 24, BE 0 on room air 4/1
Laboratory data- CBC, electrolytes, coagulation testing, liver and renal function panel, C-reactive protein level, and lactate was obtained. The following were considered abnormal:
· Lymphocytes 750/microliter
· Platelets 100,000/microliter
· C-reactive protein 3 mg/L
· Lactate 1.5 mmol/L
The patient was screened for influenza type A and B- both were negative.
The patient was also swabbed for Covid-19 due to potential community exposure with a real time reverse transcriptase-polymerase chain reaction (rRT-PCR) assay (nasal and pharyngeal). The patient was admitted for observation until the results of the assay were confirmed/ruled out and placed in droplet/airborne/contact isolation as a precaution.
The next day the results of the rRT-PCR confirmed the presence of Covid-19 infection. The patient remained stable until repeat examination and diagnostic testing on 4/7 revealed:
Vital signs- BP 140/90, HR 120, RR 28, Sp02 90% on RA
Bilateral breath sounds- crackles/rales heard in both lung bases
ABG- pH 7.35, PaC02 44 mmHg, Pa02 60 mmHg, HC03 22, BE -2 on room air
CXR- bilateral patchy opacities indicative of atypical pneumonia
Physician’s Plan
The patient was placed on supplemental oxygen at 2 liters/min via nasal cannula. The following medications were given while admitted to the hospital:
· Vancomycin
· Cefepime
· Remdesivir
· Guaifenesin
· Acetaminophen
· Intravenous normal saline
Continue to isolate the patient and monitor symptoms of Covid-19. Report incidence to CDC and local health department.
Assessment and Plan